Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06979648 · ClinicalTrials.gov registry record · NA
Effectiveness of Qualia Magnesium+® Supplementation on RBC Magnesium Levels
A NA study, sponsored by Qualia Life Sciences.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT06979648 is a NA study that has not yet begun recruiting, run by Qualia Life Sciences. The registered enrollment target is 100 participants.
The verdict
NCT06979648, a NA study, has not yet begun recruiting, sponsored by Qualia Life Sciences.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, placebo-controlled parallel trial designed to evaluate the effectiveness of Qualia Magnesium+® supplementation on red blood cell (RBC) magnesium levels in adults aged 21 and older. Approximately 100 participants with baseline RBC magnesium levels below 6.0 mg/dL will be randomly assigned to receive either Qualia Magnesium+ or a placebo. Participants will take 2 capsules daily in the evening, with or without food, for a duration of 12 weeks. The primary outcome is the between-group change in RBC magnesium levels from baseline to Week 12. Secondary outcomes include assessments of sleep quality, perceived stress, magnesium status, and safety and tolerability. Data collection will occur through lab bloodwork and electronic questionnaires.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Qualia Magnesium+®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-05-21 |
| Est. Completion | 2025-09-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06979648
The ClinicalTrials.gov registry entry for NCT06979648 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Qualia Life Sciences, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06979648 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06979648 about?
NCT06979648 is a clinical study titled "Effectiveness of Qualia Magnesium+® Supplementation on RBC Magnesium Levels". This is a randomized, double-blind, placebo-controlled parallel trial designed to evaluate the effectiveness of Qualia Magnesium+® supplementation on red blood cell (RBC) magnesium levels in adults aged 21 and older. Approximately 100 participants with baseline RBC magnesium levels below 6.0 mg/dL w...
What is the current status of trial NCT06979648?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-05-21. Estimated completion is 2025-09-21.
What interventions are being tested in trial NCT06979648?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Qualia Magnesium+® (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06979648?
This trial is sponsored by Qualia Life Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.